D-day for cancer woman.Byline: By Alison Dayani A BIRMINGHAM breast cancer victim denied life-saving drug Herceptin was today finding out if health bosses will overturn their decision in a case review. Mum-of-two Sue Jordan was told by debt-ridden North Birmingham Primary Care Trust that her tumour was 3mm too small to get the miracle drug mir·a·cle drug n. A usually new drug that proves extraordinarily effective. . But trust bosses were today reconsidering the case after Sue's plight was highlighted by the Birmingham Mail The Birmingham Mail is a tabloid newspaper based in Birmingham, UK but distributed around Birmingham, The Black Country, Solihull, Warwickshire and parts of Worcestershire and Staffordshire. . Mrs Jordan, aged 48, of Thorney Road, Streetly, said she was nervously waiting by the phone and hoping for a U-turn. "The review will take place today and I am just anxiously waiting," said Mrs Jordan. "It would be amazing to find out I can have the drug." Mrs Jordan has already had a breast removed in a battle against an aggressive form of cancer and doctors have recommended that she is prescribed Herceptin to stop the small amount of cancer left ever growing back to a dangerous level. A PCT (Private Communications Technology) A protocol from Microsoft that provides secure transactions over the Web. See security protocol. panel had refused to fund a pounds 20,000 course of the expensive life-saving drug, despite the recommendation by two consultants. But time is of the essence A phrase in a contract that means that performance by one party at or within the period specified in the contract is necessary to enable that party to require performance by the other party. Failure to act within the time required constitutes a breach of the contract. as she only has until June 22 - six months after the hemotherapy treatment - for the drug to be effective. The PCT told Mrs Jordan, who has 17-year-old twins Laura and Sarah, the amount of cancer remaining is now slightly too small to qualify for the drug. Herceptin would reduce the chance of the cancer growing back by 50 per cent. The Primary Care Trust said funding of Herceptin is based on guidelines set by Birmingham and Black Country Health Authority. CAPTION(S): SUE JORDAN. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion